Healthcare Artificial Intelligence Market: Global Forecast to 2027
Report Highlights: The global healthcare artificial intelligence (AI) market is expected to grow at a CAGR of 41.4% from 2020 [...]
Six Payer Executives to Watch in 2021
The past year has forced health plans to nimbly adapt to the demands of a global pandemic, including massive spikes [...]
Improving Peer Review in Economics
Three experimental economists, Gary Charness (UCSB), Anna Dreber (SSE) and Severine Toussaert (Oxford), are conducting a 15-20 min anonymous survey [...]
Response to NICE Methods of Health Technology Evaluation
NICE recently posted a consultation entitled "The NICE methods of health technology evaluation: the case for change". which detailed its [...]
New Healthcare Venture from Uber Health’s Dan Trigub
Trigub and co-founder Inna Plumb have launched MedArrive as a new care management platform that enables healthcare providers and payers [...]
ICER Analytics™ Accelerates Real-World Application of ICER Reports
The Institute for Clinical and Economic Review (ICER) today formally launched ICER Analytics™, a new cloud-based platform that will revolutionize the [...]
Disruption and Transformation in the COVID Era: 5 Pharma Trends for 2021
The prospective pharmaceutical industry trends first identified by Tribeca Knowledge in late 2019 were all pre-COVID, even though they continue to unfold. [...]
AMCP Nexus 2020: The Specialty Pharmacy Pipeline
The specialty pharmaceutical market is continuing to see increased competition, and in the past 10 years, there has been a [...]
Innovative Payments, Management are Needed for Cell and Gene Therapies
Cell and gene therapies are a transformative approach that provides new therapeutic options for patients with cancer, immune disorders, hemophilia, [...]
MMIT Partners With Leading Patient Access Hubs
Understanding market access is hard. Tracking shifts in coverage and payer policies for pharmaceutical products is even harder. MMIT partners [...]
Is Real-World Evidence Used in P&T Monographs and Therapeutic Class Reviews?
Little is known about when and what types of real-world evidence (RWE) studies inform pharmacy and therapeutic (P&T) committee decisions. [...]
CMS Announces Drug Payment Reductions with the “Most Favored Nation” Effective January 1, 2021
Centers for Medicare and Medicaid Services (CMS) announced the long-awaited seven year Most Favored Nation (MFN) model as an interim [...]
Reimbursing Innovative and Potentially Curative Gene and Cell Therapies
In this feature, following his participation in a workshop at the International Society for Pharmacoeconomics and Outcomes Research’s 2020 Asia Pacific [...]
Government, Big Pharma, and The People: A Century of Dis-Ease
It can be said that society shapes our values toward drugs and drugs shape society. And while drug prices are [...]
Biden Defers to Experts on COVID-19 Vaccine Prioritization
There will likely be a limited supply of coronavirus vaccine doses available immediately after a vaccine is authorized by the [...]
Digital Approaches in the Era of COVID-19
Recently Mariah Baltezegar, MBA, Executive Director and Head of Peri- and Post-Approval Virtual Trials with Evidera, and Niklas Morton, MSc, [...]
ICER Opens Nominations for New Members of Its Voting Panels
The Institute for Clinical and Economic Review (ICER) is seeking nominations for new members to join its independent evidence review [...]
[Ebook] The Role of Real-world Evidence in FDA Approvals
Global biopharma companies are increasingly using RWE to strengthen regulatory submissions. Aetion’s new eBook is designed to help inform your [...]
Mapping the Landscape of COVID-19 Clinical Trials in the US
An extraordinary amount of global research is underway as the COVID-19 pandemic continues to evolve and spread. As several entities [...]
Elements of Pharmaceutical/Biotech Pricing Short Course
ISPOR announced that it will hold a 4-hour short course entitled ‘Elements of Pharmaceutical/Biotech Pricing Short Course’ on December 9, [...]
Virtual ISPOR 2021 Abstract Submission Deadline Extended
Given the constraints of the current environment, ISPOR has extended the deadline for issue panel and workshop proposals to December [...]
Cytel Acquires Purple Squirrel Economics
Cytel Inc., a leading provider of advanced analytics for the life sciences industry, has announced the acquisition of Purple Squirrel [...]
ICER Analytics™ Launched to Accelerate the Real-World Application of ICER Reports
The Institute for Clinical and Economic Review (ICER) today formally launched ICER Analytics™, a new cloud-based platform that will revolutionize [...]
[Webinar] How Payers, the Life Science Industry, and Others Can Move from Insight to Action
On December 17, 2020, from 10:00 to 11:00 a.m. EST, ICER will host a webinar to demo ICER Analytics™, a [...]
Informed Consent in the Context of COVID-19
Clinical research is world widely speeding in order to identify as soon as possible COVID-19 treatment and vaccine. Clinical trials [...]